Ferroptosis and Pyroptosis Co‐Activated Nanomodulator for “Cold” Tumor Immunotherapy and Lung Metastasis Inhibition
Authors:
- 26 May 2023
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (37)
Abstract
Immune checkpoint blockade (ICB) therapy is an emerging strategy for cancer immunotherapy; however, the actual effects of ICB therapy are greatly limited by the immunosuppressive tumor microenvironment (TME, i.e., “cold” tumors). Although engineered nanomaterials display significant importance to regulate TME in cancer treatment, most of them focus on “immunosilent” apoptotic processes that cannot elicit sufficient immune responses for further immunotherapy. Herein, a GSH‐responsive nanomodulator is reported that can reverse the immunosuppressive TME for “cold” tumor immunotherapy and lung metastasis inhibition through simultaneous ferroptosis and pyroptosis induction. The nanomodulator is constructed by loading FDA‐approved sulfasalazine (SAS) and doxorubicin (DOX) on disulfide‐doped organosilica hybrid micelles, where SAS and DOX are released through the GSH‐stimulated rupture of micelles to induce ferroptosis and pyroptosis, respectively, promoting dendritic cells (DCs) maturation and cytotoxic T lymphocytes (CTLs) elevation through massive tumor‐associated antigen release. In vivo experimental results verify that desirable tumor destruction of the nanomodulator at low concentrations is achieved. More importantly, combination of this nanomodulator and programed death ligand‐1 antibodies significantly inhibits primary tumors and distant lung metastases as a result of elevated mature DCs and CTLs. This strategy to modulate immunosuppressive TME by nanomodulator‐induced non‐apoptotic death provides a new promising paradigm for ICB therapy.Keywords
Funding Information
- National Natural Science Foundation of China (81972172, 51621002, 51972112)
This publication has 66 references indexed in Scilit:
- The Journey from Discoveries in Fundamental Immunology to Cancer ImmunotherapyCancer Cell, 2015
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Mitochondria: In Sickness and in HealthCell, 2012
- Cancer immunotherapy comes of ageNature, 2011
- System xc‐ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNSBritish Journal of Pharmacology, 2011
- Mechanisms regulating cytochrome c release in pancreatic mitochondriaGut, 2008
- Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+increase are reciprocally modulated in rat cardiomyocytesExperimental & Molecular Medicine, 2006
- Mechanisms of cytochrome c release from mitochondriaCell Death & Differentiation, 2006
- Electron Transfer between Cytochrome c and p66Shc Generates Reactive Oxygen Species that Trigger Mitochondrial ApoptosisCell, 2005